scispace - formally typeset
E

Emma Allen-Vercoe

Researcher at University of Guelph

Publications -  143
Citations -  28476

Emma Allen-Vercoe is an academic researcher from University of Guelph. The author has contributed to research in topics: Microbiome & Biology. The author has an hindex of 42, co-authored 117 publications receiving 24132 citations. Previous affiliations of Emma Allen-Vercoe include Queen's University & Veterinary Laboratories Agency.

Papers
More filters
Journal ArticleDOI

Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut.

TL;DR: This proof-of-principle study demonstrates that a stool substitute mixture comprising a multi-species community of bacteria is capable of curing antibiotic-resistant C. difficile colitis.
Journal ArticleDOI

A Catalog of Reference Genomes from the Human Microbiome

TL;DR: Results from an initial reference genome sequencing of 178 microbial genomes allow for ~40% of random sequences from the microbiome of the gastrointestinal tract to be associated with organisms based on the match criteria used, suggesting that the authors are still far from saturating microbial species genetic data sets.
Journal ArticleDOI

Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health

TL;DR: Current knowledge of how macronutrient metabolism by the gut microbiome influences human health is summarized and knowledge gaps that could contribute to the understanding of overall human wellness will be identified.
Journal ArticleDOI

Towards standards for human fecal sample processing in metagenomic studies

Paul I. Costea, +60 more
- 02 Oct 2017 - 
TL;DR: A standardized DNA extraction method for human fecal samples is recommended, for which transferability across labs was established and which was further benchmarked using a mock community of known composition to improve comparability of human gut microbiome studies and facilitate meta-analyses.
Journal ArticleDOI

Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host.

TL;DR: This study indicates that colonization of the intestinal mucosa by highly invasive strains of F. nucleatum may be a useful biomarker for gastrointestinal disease.